dactinomycin has been researched along with vx680 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbel, J; Higgins, M; Lain, S; Lane, DP; Rao, B; Thompson, AM; van Leeuwen, IM | 1 |
1 other study(ies) available for dactinomycin and vx680
Article | Year |
---|---|
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy.
Topics: Aneugens; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Dactinomycin; Dose-Response Relationship, Drug; Gene Knockout Techniques; Genes, p53; HCT116 Cells; Humans; Imidazoles; Neoplasms; Piperazines; Protein Serine-Threonine Kinases | 2010 |